| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 13 Feb 2025 | 10 Feb 2025 |
| BROOKS LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2025 inter alia to consider and approve Unaudited Financial Results (Standalone and Consolidated) for the quarter and nine months ended December 31 2024 along with Limited Review Report of Statutory Auditors of the Company thereon pursuant to Regulation 33 of the Securities and Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulations 2015. Outcome of Board Meeting under Regulation 30 & Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015 (As per BSE Announcement Dated on 13/02/2025) Revision of the outcome of the Board Meeting held on 13th February 2025. (As Per Bse Announcement Dated on 25.02.2025) | ||
| Board Meeting | 26 Dec 2024 | 26 Dec 2024 |
| Appointment Ms Krutika Mohan Rane as Company Secretary and Compliance Officer wef from 26 Dec 2024 | ||
| Board Meeting | 11 Dec 2024 | 7 Dec 2024 |
| BROOKS LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/12/2024 inter alia to consider and approve fund raising through preferential issue of equity shares Board of Directors approved as follow - 1) FUND RAISE OF UPTO RS. 75.00 CRORES THROUGH ISSUE OF EQUITY SHARES ON PREFERENTIAL BASIS 2) FORMATION OF FUND RAISING COMMITTEE (As Per Bse Announcement Dated on 11.12.2024) | ||
| Board Meeting | 9 Nov 2024 | 6 Nov 2024 |
| BROOKS LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/11/2024 inter alia to consider and approve the Unaudited Standalone & Consolidated Financial Results of the Company for the quarter and half year ended September 30 2024. Outcome of Board Meeting under Regulation 30 & Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015 (As Per BSE Announcement dated on 09.11.2024) | ||
| Board Meeting | 14 Aug 2024 | 6 Aug 2024 |
| BROOKS LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2024 inter alia to consider and approve the Unaudited Standalone & Consolidated Financial Results of the Company for the quarter ended on June 30 2024 Outcome of Board Meeting (As per BSE Announcement Dated on 14/08/2024) | ||
| Board Meeting | 7 Aug 2024 | 7 Aug 2024 |
| Appointment of Additional Independent Director(s). | ||
| Board Meeting | 18 May 2024 | 12 May 2024 |
| BROOKS LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 18/05/2024 inter alia to consider and approve Audited Standalone and Consolidated Financial Results of the company for the quarter and year ended 31st March 2024. Board Meeting Outcome For Submission of Audited Standalone And Consolidated Financial Results For Quarter And Financial Year Ended March 31, 2024. Financial Results for Quarter and Financial Year ended March 31,2024 (As Per BSE Announcement Dated on 18.05.2024) | ||
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
